Inhibition of both c-Met and EGFR signaling shows synergistic antitumor activity in non-small cell lung cancer model

被引：1
|
作者：
Tammam, Jennifer G.
Davis, Lenora
Ware, Chris
Reilly, John F.
Deshmukh, Sujal V.
Dinsmore, Christopher
Marshall, Gary
Harrington, Elizabeth A.
Pan, Bo-Sheng
Lutterbach, Bart A.
Majumder, Pradip K.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C209
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Analytical performance of a diagnostic immunohistochemical assay for MET protein (c-Met) in non-small cell lung cancer
    Inge, L.
    Admire, B.
    Foutch, T.
    Landowski, T.
    Lopez-Schultz, M.
    Gordon, K.
    Kapdia, M.
    Zhang, L.
    Mistry, A.
    Hotson, A.
    Bheddah, S.
    Li, M.
    McKee, L.
    VIRCHOWS ARCHIV, 2024, 485 : S141 - S141
  • [32] Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells
    Nam, A-Young
    Joo, Sang Hoon
    Khong, Quan T.
    Park, Jisu
    Lee, Na Yeong
    Lee, Seung-On
    Yoon, Goo
    Park, Jin Woo
    Na, Minkyun
    Shim, Jung-Hyun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers
    Tsuta, K.
    Yoshida, A.
    Tsuda, H.
    LABORATORY INVESTIGATION, 2011, 91 : 426A - 426A
  • [34] A c-met inhibitor in the treatment of metastatic non small cell lung cancer with c-met amplification.
    Zhang, Tongtong
    Li, Junling
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis
    Liang, Hongge
    Wang, Mengzhao
    ONCOTARGETS AND THERAPY, 2020, 13 : 2491 - 2510
  • [36] Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer
    Gao, Hong-Fei
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Yan, Hong-Hong
    Guo, Wei-Bang
    Zhou, Qing
    Gou, Lou-Ying
    Dong, Zhong-Yi
    Wu, Yi-Long
    ONCOTARGET, 2016, 7 (26) : 39535 - 39543
  • [37] MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer
    Zhen, Qiang
    Liu, Junfeng
    Gao, Lina
    Liu, Jiabao
    Wang, Renfeng
    Chu, Weiwei
    Zhang, Yaxiao
    Tan, Guoliang
    Zhao, Xiaojian
    Lv, Baolei
    CYTOGENETIC AND GENOME RESEARCH, 2015, 146 (01) : 1 - 8
  • [38] Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Botting, Gregory M.
    Rastogi, Ichwaku
    Chhabra, Gagan
    Nlend, Marie
    Puri, Neelu
    PLOS ONE, 2015, 10 (08):
  • [39] Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
    Lixia Ju
    Caicun Zhou
    Cancer Cell International, 13
  • [40] Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?
    Wu, Yi-Long
    Soo, Ross Andrew
    Locatelli, Giuseppe
    Stammberger, Uz
    Scagliotti, Giorgio
    Park, Keunchil
    CANCER TREATMENT REVIEWS, 2017, 61 : 70 - 81
12345